Clinical pharmacology of dopamine agonists in Parkinson's disease.
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 13 (5) , 381-389
- https://doi.org/10.2165/00002512-199813050-00004
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's diseaseMovement Disorders, 1996
- Ropinirole in the Treatment of Levodopa-Induced Motor Fluctuations in Patients with Parkinson's DiseaseClinical Neuropharmacology, 1996
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- Pergolide can induce soluble Superoxide dismutase in rat striataJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonismAnnals of Neurology, 1988
- Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisurideLife Sciences, 1983
- Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1981
- Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclaseLife Sciences, 1978